# Antitussive Effect of Single-dose Dexmedetomidine With Low-dose Remifentanil Infusion

> **NCT02208505** · PHASE4 · COMPLETED · sponsor: **Yonsei University** · enrollment: 168 (actual)

## Conditions studied

- Thyroidectomy

## Interventions

- **DRUG:** Dexmedetomidine + Remifentanil-low dose
- **DRUG:** Remifentanil-high dose

## Key facts

- **NCT ID:** NCT02208505
- **Lead sponsor:** Yonsei University
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-02
- **Primary completion:** 2015-07
- **Final completion:** 2015-12
- **Target enrollment:** 168 (ACTUAL)
- **Last updated:** 2017-10-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02208505

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02208505, "Antitussive Effect of Single-dose Dexmedetomidine With Low-dose Remifentanil Infusion". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02208505. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*